Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H23NO3 |
Molecular Weight | 385.455 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C(=O)C2=CN(CCCCC(O)=O)C3=CC=CC=C23)C4=C1C=CC=C4
InChI
InChIKey=CXHVTSVFMMQERU-UHFFFAOYSA-N
InChI=1S/C25H23NO3/c1-17-13-14-21(19-9-3-2-8-18(17)19)25(29)22-16-26(15-7-6-12-24(27)28)23-11-5-4-10-20(22)23/h2-5,8-11,13-14,16H,6-7,12,15H2,1H3,(H,27,28)
Molecular Formula | C25H23NO3 |
Molecular Weight | 385.455 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25195129Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27779402
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25195129
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27779402
MAM-2201 N-pentanoic acid metabolite is an organic compound that is closely related, structurally, to AM2201 and JWH 122, two compounds which display high affinities for both CB receptors. MAM2201 N-pentanoic acid metabolite is a phase 1 metabolite of JWH-122, but unlike JWH-122, does not show agonistic activity against CB receptors. The physiological and toxicological properties of this compound have not been evaluated.
Originator
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27779402
HEK 293T cells transfect with CB1 or CB2 receptor were used for activity evaluation. Forty-eight hours after transfection, the cells were washed twice with Opti-MEM I reduced serum medium to remove any remaining FBS, and 100 μL of Opti-MEM I was added. The Nano-Glo Live Cell reagent, a nonlytic detection reagent containing the cellpermeable furimazine substrate, was prepared by diluting the Nano-Glo Live Cell substrate 20× using Nano-Glo LCS Dilution buffer, and 25 μL was added to each well. Subsequently, the plate was placed in a GloMAX96 (Promega). Luminescence was monitored during the equilibration period until the signal was stabilized (30−45 min). For agonist experiments, we added 10 μL per well of test compounds, present as 13.5× stocks in 50% methanol in Opti-MEM I. Luminescence was continuously detected for 120 min. The luminescence was continuously detected for 120 min.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:27:36 GMT 2023
by
admin
on
Sat Dec 16 11:27:36 GMT 2023
|
Record UNII |
8RE71H2V65
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
91864527
Created by
admin on Sat Dec 16 11:27:36 GMT 2023 , Edited by admin on Sat Dec 16 11:27:36 GMT 2023
|
PRIMARY | |||
|
DTXSID201017836
Created by
admin on Sat Dec 16 11:27:36 GMT 2023 , Edited by admin on Sat Dec 16 11:27:36 GMT 2023
|
PRIMARY | |||
|
8RE71H2V65
Created by
admin on Sat Dec 16 11:27:36 GMT 2023 , Edited by admin on Sat Dec 16 11:27:36 GMT 2023
|
PRIMARY | |||
|
1537889-09-0
Created by
admin on Sat Dec 16 11:27:36 GMT 2023 , Edited by admin on Sat Dec 16 11:27:36 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
<LOQ to 3.9 ng/mL
IN-VIVO
URINE
|